Fairmount Funds Management as of March 31, 2023
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 16 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axsome Therapeutics (AXSM) | 21.3 | $124M | 2.0M | 61.68 | |
| Nuvalent Inc-a (NUVL) | 12.9 | $75M | 2.9M | 26.09 | |
| Verona Pharma Sponsored Ads (VRNA) | 10.8 | $63M | 3.1M | 20.08 | |
| Beigene Sponsored Adr (BGNE) | 8.9 | $52M | 239k | 215.53 | |
| Enliven Therapeutics (ELVN) | 7.2 | $42M | 1.9M | 21.90 | |
| Miragen Therapeutics (VRDN) | 6.0 | $35M | 1.4M | 25.44 | |
| Cogent Biosciences (COGT) | 5.1 | $30M | 2.8M | 10.79 | |
| Argenx Se Sponsored Adr (ARGX) | 4.7 | $27M | 74k | 372.58 | |
| Astria Therapeutics (ATXS) | 4.3 | $25M | 1.9M | 13.30 | |
| Terns Pharmaceuticals (TERN) | 4.2 | $24M | 2.0M | 11.84 | |
| Tyra Biosciences (TYRA) | 3.9 | $23M | 1.4M | 16.07 | |
| Theseus Pharmaceuticals | 2.8 | $17M | 1.9M | 8.88 | |
| Geron Corporation (GERN) | 2.7 | $15M | 7.1M | 2.17 | |
| Dbv Technologies Sa Sponsored Adr | 2.1 | $12M | 7.1M | 1.69 | |
| Trevi Therapeutics (TRVI) | 1.8 | $11M | 5.7M | 1.85 | |
| Merus N V (MRUS) | 1.2 | $6.9M | 374k | 18.40 |
